Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Broder

Showing results (1-10 of 451) with videos related to

Pageof 46
Sort By:
Leukemia|January 1, 1992
Factors in the development of AIDS-related lymphomasS Broder
The American Journal of Medicine|May 21, 1990
Dideoxycytidine (ddC): a potent antiretroviral agent for human immunodeficiency virus infection. An introductionS Broder
Progress in Allergy|January 1, 1986
T cell proliferation and ablation. A biologic spectrum of abnormalities induced by the human T cell lymphotropic virus groupS Broder
JAMA|December 26, 2001
Samuel Broder, MD, reflects on the 30th anniversary of the National Cancer Act. Interviewed by Brian VastagS Broder
JAMA|April 8, 1992
From the National Institutes of HealthS Broder
The American Journal of Medicine|May 21, 1990
Pharmacodynamics of 2',3'-dideoxycytidine: an inhibitor of human immunodeficiency virusS Broder
The New England Journal of Medicine|May 19, 1994
Fraud in breast-cancer trialsS Broder
Annals of Internal Medicine|March 15, 1989
Controlled trial methodology and progress in treatment of the acquired immunodeficiency syndrome (AIDS). A quid pro quoS Broder
Seminars in Oncology|June 1, 1990
The interrelationship between acquired immunodeficiency syndrome and cancer researchS Broder
Stem Cells (Dayton, Ohio)|January 1, 1993
The challenge of cancer researchS Broder
Pageof 46

Showing results (1-10 of 451) with videos related to

Sort By:
Pageof 46
Leukemia|January 1, 1992
Factors in the development of AIDS-related lymphomasS Broder
The American Journal of Medicine|May 21, 1990
Dideoxycytidine (ddC): a potent antiretroviral agent for human immunodeficiency virus infection. An introductionS Broder
Progress in Allergy|January 1, 1986
T cell proliferation and ablation. A biologic spectrum of abnormalities induced by the human T cell lymphotropic virus groupS Broder
JAMA|December 26, 2001
Samuel Broder, MD, reflects on the 30th anniversary of the National Cancer Act. Interviewed by Brian VastagS Broder
JAMA|April 8, 1992
From the National Institutes of HealthS Broder
The American Journal of Medicine|May 21, 1990
Pharmacodynamics of 2',3'-dideoxycytidine: an inhibitor of human immunodeficiency virusS Broder
The New England Journal of Medicine|May 19, 1994
Fraud in breast-cancer trialsS Broder
Annals of Internal Medicine|March 15, 1989
Controlled trial methodology and progress in treatment of the acquired immunodeficiency syndrome (AIDS). A quid pro quoS Broder
Seminars in Oncology|June 1, 1990
The interrelationship between acquired immunodeficiency syndrome and cancer researchS Broder
Stem Cells (Dayton, Ohio)|January 1, 1993
The challenge of cancer researchS Broder
Pageof 46